Treatment of human brain tumor xenografts with O6-benzyl-2′-deoxyguanosine and BCNU

Cancer Research

Volumn 56, Issue 9, 1996, Pages 2076-2081

  Schold Jr , S Clifford ^a   Kokkinakis, Demetrius M ^a   Rudy, Jack L ^a   Moschel, Robert C ^b   Pegg, Anthony E ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O BENZYL 2' DEOXYGUANOSINE; ANTINEOPLASTIC AGENT; CARMUSTINE; DAUNORUBICIN; DEOXYGUANOSINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG SOLUBILITY; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARMUSTINE; CELL DEATH; DEOXYGUANOSINE; HUMANS; METHYLTRANSFERASES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029920702     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ayash, L. J., Herman, T. S., and Frei, E., III. Cancer chemotherapy: clinical evidence for drug resistance. In: B. A. Teicher (ed.). Drug Resistance in Oncology, pp. 617-635. New York: Marcel Dekker, 1993.
2. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenesis and therapeutic agents. Cancer Res., 50. 6119-6129, 1990.
3. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl. Acad. Sci. USA, 87. 5368-5372, 1990.
4. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res , 51: 3367-3372, 1991
5. 6-alkylguanine-DNA alkyltransferase J. Med Chem., 35: 4486-4491, 1992.
6. 2-methyl derivative. J Og. Chem., 34: 2160-2163, 1969.
7. 6-substituted 2′-deoxyguanosine residues at the first, second, or both positions of codon 12. Chem. Res. Toxicol., 1. 391-397, 1988.
8. Friedman, H. S., Colvin, O. M., Skapek, S. X., Ludeman, S. M., Elion, G. B , Schold, S. C , Jr., Jacobsen, P. F , Muhlbaier, L H , and Bigner, D D. Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents Cancer Res , 48 4189-4195, 1988
9. Friedman, H S., Dolan, M. E., Moschel, R. C , Pegg, A. E., Felker, G. M., Rich, J , Bigner, D D , and Schold, S. C Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. J. Natl. Cancer Inst., 84: 1926-1931, 1992.
10. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Chemother. Pharmacol., 32: 471-476, 1993.
11. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
12. 6-methylguanine-DNA transmethylase from rat liver J Biol. Chem., 258: 2327-2333, 1983.
13. Kokkinakis, D. M., and Scarpelli, D G. DNA alkylation in the hamster induced by two pancreatic carcinogens. Cancer Res., 49: 3184-3189, 1989.
14. Wyllie, A. H , Kerr, J. F., and Currie, A R. Cell death: the significance of apoptosis. Int. Rev Cytol., 68: 251-306, 1980.
15. Hickman J. A. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev., 11: 121-139, 1992.
16. 6-Alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea. Proc Natl. Acad. Sci. USA, 82: 2985-2989, 1985.
17. 6-Alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts. J. Neurosurg., 70: 573-577, 1989.
18. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone. Biochem. Pharmacol., 45. 483-491, 1993.
19. 6-benzylguanine in vitro. Carcinogenesis (Lond.), 14: 1057-1060, 1993.
20. 6-benzyl-2′-deoxyguanosine in Sprague-Dawley rats. Chem. Res. Toxicol., 7: 762-769, 1994.
21. 6-benzyl-2′-deoxyguanosine. Role of metabolism. In Vivo, in press, 1996.
22. Desoize, B. Anticancer drug resistance and inhibition of apoptosis. Anticancer Res., 14: 2291-2294, 1994.
23. Martin, S. J., and Green, D R Apoptosis as a goal of cancer therapy, Curr. Opin. Oncol., 6. 616-621, 1994.
24. Haldar, S., Negrini, M., Monne, M., Sabbioni, S., and Croce, C. M. Downregulation of bcl-2 by p53 in breast cancer cells. Cancer Res., 54: 2095-2097, 1994.
25. Dive, C., Evans, C A., and Whetton, A. D. Induction of apoptosis-new targets for cancer therapy Cancer Biol , 3: 417-427, 1992.
26. Barry, M. A., Behnke, C A., and Eastman, A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins, and hyperthermia. Biochem. Pharmacol., 40: 2353-2362, 1990
27. Milas, L , Hunter, N. R., Kurdoglu, B., Mason, K. A., Meyn, R. E., Stephens, L. C., and Peters, L J. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother. Pharmacol., 35: 297-303, 1995
28. Stephens, L. C., Hunter, N. R , Ang, K. K., Milas, L , and Meyn, R. E. Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat Res., 135 75-80, 1993.